Aichi - Research on Combination therapy in Hypertension (ARCH): Multi-center observational study on hypertensive's actual condition and effectiveness of the patient preference on an ARB and diuretic combination therapy in hypertensive patients who are under drug treatment
Phase 4
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000000816
- Lead Sponsor
- Hypertension Academy in NAGOYA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria 1. Patients with the secondary hypertension 2. Patients with cardiac insufficiency (above NYHA grade III) 3.Women who are pregnant (positive urine pregnancy test at prestudy) or breast feeding, or expecting to conceive duration the study period 4. Patients with a critical liver damage 5. Patient with a history of severe hepatic or renal disease (sCr>2.0mg/dl) 6. Patients with a history of hypersensitivity to ingredients of Preminent. 7. Patients with a history of hypersensitivity to components of thiazide or similar compounds. 8. Patients who are considered to be not eligible to the study by the investigator due to medical reasons.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Systolic-blood-pressure change in three-month treatment.
- Secondary Outcome Measures
Name Time Method 1.The rate of achieving the target SBP-DBP in three-month treatment 2.DBP change in the three-month treatment 3.The SBP/DBP changes and the rates of achieving the target blood pressure at 3,6, and 12 months 4.The rate of continued treatment and the compliance of the treatment 5.Rates of adverse experiences 6.Subanalysis on patient characteristics between the groups which achieves target blood pressure and which des not